IDH2 and central nervous system cancer: Of the five reported, genetically characterized intracranial xenografts, all had 1p/19q co-deletion, but only one, which was an anaplastic oligoastrocytoma, or a mixed glioma, was found to express a mutated IDH protein, R132H [22].